Announcements Trials
Browse Landscape

Phase

Phase 2 9Phase 1 9Phase 3 5Phase NA 2Phase 4 1Phase 2/3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 24Other hematologic neoplasm 20Tumor-Agnostic 2Other solid neoplasm 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Retinoblastoma 1

Interventions

Pemetrexed 3sacituzumab govitecan 1ribociclib 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1encorafenib 1binimetinib 1Vincristine 1Sunitinib 1Sirolimus 1Raltegravir Potassium 1Paclitaxel 1One-Lung Ventilation 1Midazolam 1Leucovorin 1Itraconazole 1Irinotecan 1Immune Checkpoint Inhibitors 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Drug Therapy 1Clinical Trials, Phase I as Topic 1Cetuximab 1Carboplatin 1Bevacizumab 1Anesthesia, General 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Vincristine × Other solid neoplasm × Clear all
NCT02319486 2015-03-30

CEV With/Without Periocular Carboplatin Chemotherapy for Extraocular Retinoblastoma

Sun Yat-sen University

Phase 4 Completed
26 enrolled 7 charts
Other solid neoplasm

Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡